Some patients have a very good chance of achieving remission after donor lymphocyte infusions (such as patients with early stages of CML). Standard DLI after allogeneic BMT have been less effective for patients with advanced leukemia (AML, ALL, or "accelerated phase" and "blast crisis" CML), or patients with other diseases such as myelodysplasia, CLL, Hodgkin's lymphoma and non-Hodgkin's lymphoma. Because of your disease, your physician estimates a chance of less than 4 in 10 (40%) or less of responding to standard donor lymphocyte infusions (DLI).